|
Ms. Parshall is Director, Executive Vice President, Chief Financial Officer and Secretary of Isis Pharmaceuticals. She is responsible for overseeing the operations of finance, legal, regulatory affairs, and patents and is also very involved in the Company's corporate communications and business development activities. Ms. Parshall has been with Isis for 15 years. Previously, Ms. Parshall was a Partner with the firm of Cooley Godward LLP where she represented several health care companies in a general practice specializing in corporate partnering and other technology-based transactions.
Ms. Parshall received her J.D. at Stanford Law School, Stanford, California and her B.A. from Harvard University, Cambridge, Massachusetts. Ms. Parshall is currently on the board of Corautus Genetics, Inc., CardioDynamics International Corporation and is a Trustee of The Bishop School in La Jolla. Ms. Parshall is also a member of the Licensing Executives Society and a member of the American, Californian, and San Diego bar associations.
| 